发明名称 GENETICALLY MODIFIED RAT MODELS FOR PAIN
摘要 This invention relates to the engineering of animal cells, preferably mammalian, more preferably rat, that are deficient due to the disruption of gene(s) or gene product(s) resulting in altered nervous system function. In one aspect, the altered function results in pain in the mammal. In another aspect, the nervous system dysfunction results in prolonged hyperalgesia, allodynia, and loss of sensory function. In another aspect, the invention relates to genetically modified rats, as well as the descendants and ancestors of such animals, which are animal models of altered nervous system function mediated pain and methods of their use. In another aspect, the genetically modified rats, as well as the descendants and ancestors of such animals, are animal models of nervous system dysfunction resulting in prolonged hyperalgesia, allodynia, and loss of sensory function and methods of their use. In another aspect, the present invention provides a method of identifying a compound useful for the treatment or prevention of pain.
申请公布号 WO2011022634(A3) 申请公布日期 2011.04.21
申请号 WO2010US46144 申请日期 2010.08.20
申请人 TRANSPOSAGEN BIOPHARMACEUTICALS, INC.;OSTERTAG, ERIC;CRAWFORD, JOHN, STUART 发明人 OSTERTAG, ERIC;CRAWFORD, JOHN, STUART
分类号 A01K67/027 主分类号 A01K67/027
代理机构 代理人
主权项
地址